Inspire Veterinary Partners, Inc. · OTC:IVPR
Inspire Veterinary Partners — Investor Presentation (May 2025)
17 slides from Inspire Veterinary Partners's investor presentation, May 2025
Slide 1: Investor Presentation
Investor Presentation Nasdaq: IVP
Slide 2: Forward Looking Statement
Forward Looking Statement This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “
Slide 3: Contents
Inspire Veterinary Partners Contents Industry Overview Description of Business YE 2024, Operational and Growth Initiatives Acquisition Workflow Process and Differentiators Team / Personnel Build Out www.inspirevet.com Outlook for 2025 and Beyond 3
Slide 4: Industry Overview: Consolidation Underway
Industry Overview As of 2023, consolidation has been underway for over a decade National Consolidators 13+ Mars, National Veterinary Associates, Southern Veterinary Partners, others. Regional Consolidators ~30 Vet Partners, Heart + Paw, Innovetive, Destination Pet, others. www.inspirevet.com 9 Speci
Slide 5: Industry Remains Largely Unconsolidated
Industry Overview Industry Remains Largely Unconsolidated The global pet care market is expected to grow from $246 billion in 2023 to $368 billion by 2030, with spending on veterinary services in the U.S. alone exceeding $38 billion in 2023. Today, the veterinary care industry consists of more than
Slide 6: Inspire At A Glance
Inspire At A Glance Inspire Defined Inspire is an owner of general practice veterinary clinics in the United States. Inspire acquires practices, and, in many cases real estate, and then works with teams on a long- term basis to improve and maintain hospital operations, grow revenues and maximize ear
Slide 7: Twelve Month 2024 Financial Highlights
Twelve Month 2024 Financial Highlights • Total revenue of approximately $16.6 million, flat year-over–year • Services revenue increased 3% to approximately $12.2 million • Product revenue decreased 8% to $4.4 million • Total operating expenses increased by 7% • Net loss decreased by $0.5 million or
Slide 8: Growth Strategy
Growth Strategy Strengthened Balance Sheet Driving Additional Financial Flexibility to Access Multiple Paths to Revenue Growth and Earnings • Expansion in 2025 through hospital acquisitions and new business integrations by targeting single unit acquisitions and the potential for multi-unit integrati
Slide 9: Acquisition Process & Strategy
Acquisition Process & Strategy Owner interviews conducted, 3 years of financials thoroughly reviewed, staffing census completed, case Post closing, 90-day transition mix and demographics analyzed, offer for practice built plan already in place, growth based on a combination of predictive factors. *O
Slide 10: A Differentiated Approach
A Differentiated Approach Our approach and the diversity of our team is truly differentiated Inspire supports its hospitals with Inspire has infused its founding group, 1 2 traditional field leadership in the form of operations and veterinary leadership operations and medical field leaders. In teams
Slide 11: Why Do Inspire's Advantages Matter?
Why Do Inspire’s Advantages Matter? Attracting and Retaining Talent Are Key Our ability to offer equity to employees isn’t just altruistic, it’s a strategic retention tool. Operational Acumen At Scale Our leadership team possesses a unique combination of leadership at enterprise scale within VetMed,
Slide 12: Inspire's Business Today
Inspire’s Business Today Our consultative and geographically distributed leadership model allow us to operate throughout the United States and we are seeking acquisition targets nationwide. We are not bound by a ‘hub and spoke’ growth methodology allowing us to be agile in examining potential acquis
Slide 13: Experienced Leadership
Experienced Leadership Inspire is led by a team of proven professionals Kimball Carr, President & CEO Richard Frank, CFO 30 years of operations, multiunit and Decades of finance experience as VetMed experience with public and CFO and COO for private and public private companies. companies. Dr. Alex
Slide 14: Scaling to profitability and the next phase of growth
Scaling to profitability and the next phase of growth Field & HQ Leadership Investments Key leadership roles added to foster ops excellence, enhance internal controls and improve reporting capabilities. Strengthening Inspire’s Capabilities Existing staff enhanced by new personnel with experience in
Slide 15: Building Out The Organizational Structure
Building Out The Organizational Structure Key personnel added and planned in 2024 / 2025 VP of Operations Director of FP&A Manager of Commercial and AP Marketing and BD Adds www.inspirevet.com 15
Slide 16: 2025 and Beyond
2025 and Beyond Next phase of growth Continue GP Purchases with Expansion Into Emergency/Critical Care Multi-Unit Purchases, Expansions And Relos, Potential for De Novo Service Expansion: Pet Resorts, www.inspirevet.com Boarding New Verticals In Tech, Lab And Ancillary Services 16
Slide 17: Thank You.
Thank You. TraDigital IR Kevin McGrath (646) 418-7002 kevin@tradigitalir.com Inspire Veterinary Partners www.inspirevet.com Nasdaq: IVP 17
Inspire Veterinary Partners — Investor Presentation (May 2025) on 6ix